Principia Biopharma Inc. (PRNB): Price and Financial Metrics
PRNB Price/Volume Stats
| Current price | $100.05 | 52-week high | $101.89 |
| Prev. close | $99.95 | 52-week low | $25.35 |
| Day low | $99.95 | Volume | 1,792,700 |
| Day high | $100.37 | Avg. volume | 729,676 |
| 50-day MA | $94.52 | Dividend yield | N/A |
| 200-day MA | $68.53 | Market Cap | 3.32B |
PRNB Stock Price Chart Interactive Chart >
Principia Biopharma Inc. (PRNB) Company Bio
Principia Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on developing novel oral therapies for immunology and oncology in the United States. It is developing PRN1008, an inhibitor that is in Phase II clinical trial for the treatment of pemphigus, a chronic skin disease, as well as in Phase II clinical trial for the treatment of immune thrombocytopenic purpura; PRN2246, an inhibitor that is in Phase I clinical trial for the treatment of multiple sclerosis and other central nervous system diseases; PRN1371, a drug candidate, which is in Phase I clinical trial for the treatment of solid tumors; and oral small molecule inhibitors of the immunoproteasome. The company has collaboration agreements with Genzyme Corporation and AbbVie Biotechnology Limited. Principia Biopharma Inc. was founded in 2008 and is based in South San Francisco, California.
PRNB Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Continue Researching PRNB
Here are a few links from around the web to help you further your research on Principia Biopharma Inc's stock as an investment opportunity:Principia Biopharma Inc (PRNB) Stock Price | Nasdaq
Principia Biopharma Inc (PRNB) Stock Quote, History and News - Yahoo Finance
Principia Biopharma Inc (PRNB) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...